Right ventricular abnormalities in sickle cell anemia: evidence of a progressive increase in pulmonary vascular

Naveen Qureshi1, James J Joyce, Ning Qi

  • 1Department of Pediatrics, David Geffen School of Medicine at UCLA, Torrance and Los Angeles, CA, USA. nqureshi@mail.cho.org

Insights

Sickle cell anemia (SCA) increases right ventricle (RV) mass and pulmonary hypertension risk in children. However, RV preload and systolic function remain stable during childhood in SCA patients.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Cardiovascular Research

Background:

  • Sickle cell anemia (SCA) is a genetic blood disorder with known cardiac complications.
  • The right ventricle (RV) is susceptible to changes in sickle cell anemia due to altered hemodynamics and pulmonary vascular resistance.

Purpose of the Study:

  • To evaluate the impact of sickle cell anemia on right ventricle structure and function in children.
  • To determine if right ventricle abnormalities progress during childhood in SCA patients.

Main Methods:

  • Echocardiographic assessment of 32 children with SCA compared to healthy controls.
  • Key RV parameters measured: diastolic area index, fractional area change, free-wall mass index, heart rate-corrected ejection time (ETc), and tricuspid regurgitation (TR) gradient.

Main Results:

  • Children with SCA exhibited elevated RV ETc, diastolic area index, and free-wall mass index compared to controls.
  • RV fractional area change was similar between SCA patients and controls.
  • RV free-wall mass index increased with age in SCA patients, and 16% of subjects showed TR gradients indicative of pulmonary hypertension.

Conclusions:

  • Right ventricle preload and systolic function are not adversely affected during childhood in SCA.
  • Progressive increases in RV mass index and the incidence of pulmonary hypertension are observed in children with SCA, correlating with increased pulmonary vascular resistance.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...